Joseph Group Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.64M Buy
4,991
+571
+13% +$264K 0.56% 46
2026
Q1
$2.12M Buy
4,420
+333
+8% +$171K 0.53% 45
2025
Q4
$2.3M Sell
4,087
-53
-1% -$30.1K 0.6% 43
2025
Q3
$2.13M Sell
4,140
-1,177
-22% -$514K 0.6% 41
2025
Q2
$1.67M Buy
5,317
+1,144
+27% +$343K 0.56% 44
2025
Q1
$1.27M Buy
4,173
+553
+15% +$186K 0.49% 44
2024
Q4
$1.2M Buy
3,620
+575
+19% +$195K 0.47% 45
2024
Q3
$1.02M Buy
3,045
+520
+21% +$198K 0.39% 45
2024
Q2
$1.04M Buy
2,525
+275
+12% +$109K 0.54% 44
2024
Q1
$909K Sell
2,250
-485
-18% -$171K 0.46% 44
2023
Q4
$838K Sell
2,735
-135
-5% -$36.4K 0.49% 42
2023
Q3
$695K Sell
2,870
-320
-10% -$81.8K 0.5% 41
2023
Q2
$766K Buy
3,190
+44
+1% +$9.14K 0.64% 41
2023
Q1
$592K Buy
3,146
+214
+7% +$44.3K 0.52% 42
2022
Q4
$623K Sell
2,932
-238
-8% -$47.5K 0.59% 43
2022
Q3
$498K Buy
3,170
+235
+8% +$37.5K 0.54% 42
2022
Q2
$439K Buy
2,935
+347
+13% +$50.2K 0.44% 44
2022
Q1
$423K Buy
2,588
+132
+5% +$21.8K 0.43% 45
2021
Q4
$535K Buy
+2,456
New +$514K 0.51% 46

Other funds holding MEDP

Joseph Group Capital Management's MEDP Position: Q2 2026 in Review

Joseph Group Capital Management increased its Medpace (MEDP) stake by 13% in Q2 2026, buying an estimated $264K and bringing the position to 4,991 shares worth $2.64M. The position accounts for 0.56% of the portfolio, ranked #46.

Joseph Group Capital Management first reported a position in MEDP in Q4 2021 and has held it in 19 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Joseph Group Capital Management held 4,991 shares of Medpace worth $2.64M as of Q2 2026.
  • Joseph Group Capital Management bought 571 Medpace shares in Q2 2026, an estimated $264K.
  • Medpace made up 0.56% of Joseph Group Capital Management's portfolio in Q2 2026, its #46 holding.
  • Joseph Group Capital Management first reported a position in Medpace in Q4 2021 and has held it in 19 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Joseph Group Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.